NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy
Business Wire•28/07/2026•16:01 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.